Senti Biosciences (SNTI) Debt to Equity (2021 - 2024)
Senti Biosciences has reported Debt to Equity over the past 2 years, most recently at $0.0 for Q3 2024.
Senti Biosciences has reported Debt to Equity over the past 2 years, most recently at $0.0 for Q3 2024.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month